MedMira
MedMira Strengthens and Expands Board
Halifax, Nova Scotia, 14 July, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the appointment of Ms. Pascale Nini to the...
top of page
MedMira
- Jun 6, 2022
- 4 min
MedMira Receives Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, June 6, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent (number 11,353,450)...
MedMira
- May 27, 2022
- 2 min
Update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
Halifax, Nova Scotia, 27 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe...
MedMira
- May 20, 2022
- 2 min
VYRA™ Product Line Update
Halifax, Nova Scotia, 20 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the Company’s regulatory work for...
MedMira
- May 12, 2022
- 2 min
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test
Halifax, Nova Scotia, 12 May, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its...
MedMira
- Mar 9, 2022
- 4 min
MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada
Halifax, Nova Scotia, 9 March, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) launches its Reveal® TP (Syphilis) product in Europe and...
MedMira
- Mar 1, 2022
- 7 min
Corporate update
In the second financial quarter of FY2022, MedMira continued its strategic plan to focus its own product portfolio on the two fastest...
MedMira
- Feb 4, 2022
- 3 min
MedMira Provides a Pre-Annual General Meeting Update
Halifax, Nova Scotia, 4 February, 2022 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides a pre-Annual General Meeting (AGM) update on...
MedMira
- Dec 21, 2021
- 2 min
MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities
Halifax, Nova Scotia, 21 December, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its VYRATMproduct line by...
MedMira
- Dec 17, 2021
- 3 min
MedMira strengthen its Board with New Appointment
Halifax, Nova Scotia, 17 December 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announced today the appointment of Mr. Thomas Bergmann...
MedMira
- Dec 14, 2021
- 2 min
MedMira announces significant debt reduction and additional growth capital
Halifax, Nova Scotia, 14 December, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces a financial package of over $5.23 million...
MedMira
- Jun 14, 2021
- 2 min
Performance Update on World Health Organisation SARS-CoV2 Serology Standards
Halifax, Nova Scotia, 14 June, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the World Health Organization (WHO) SARS-CoV-2...
MedMira
- Mar 3, 2021
- 2 min
Product and Regulatory Update on MedMira’s COVID-19 Product Family
Halifax, Nova Scotia, 03 March, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the expansion of its product portfolio and outlines...
MedMira
- Jan 29, 2021
- 2 min
Progress Update on MedMira’s COVID-19 Product Family
Halifax, Nova Scotia, 29 January, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the development of a rapid antibody test...
MedMira
- Nov 30, 2020
- 2 min
MedMira Announces Product Update
Halifax, Nova Scotia, 30 December, 2020 – Today, MedMira Inc. (MedMira) (TSXV: MIR), is pleased to announce its validated REVEALCOVID-19™...
MedMira
- Oct 7, 2020
- 2 min
MedMira reports additional independent performance evaluation results of REVEALCOVID-19™
Halifax, Nova Scotia, 7th of October, 2020 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the results of the latest independent...
MedMira
- Apr 14, 2020
- 2 min
MedMira Announces Update on Development of Point-of-Care Antibody Test
Halifax, Nova Scotia, 15th of April, 2020 – MedMira Inc. (MedMira) (TSXV: MIR), announced today that it has completed the development of...
bottom of page